Past Events
Northleaf Co-hosting Secondary Market Webinar
Matthieu Ducharme will be moderating the panel discussion on risks and opportunities for the secondary market.
Northleaf speaking at the BVCA Alternative Fund Strategy Conference
Northleaf’s Matthieu Ducharme will be speaking on a panel discussion on the future of secondaries.
Northleaf speaking at the Global ABS and Structured Finance Summit 2021
Northleaf’s Michael Morris will be speaking on a panel discussion on trends and opportunities in litigation finance in the current market environment.
Northleaf speaking at APPrO’s 32nd Annual Canadian Power Conference
Paul Bradley, Operating Partner with Northleaf’s infrastructure investment team, will be moderating a panel on changes in project finance.
Northleaf sponsoring the Canadian Investment Institute 2020 Conference
As a longtime supporter of the International Foundation, Northleaf is pleased to be a sponsor of this virtual conference.
Northleaf speaking at the Private Debt Investor Tokyo Forum 2020
Northleaf is pleased to be a lead sponsor of the conference. David Ross will be speaking on a panel discussion on how the investment landscape for private debt is developing in response to COVID-19.
Northleaf speaking at the Private Debt Investor Seoul Forum 2020
Northleaf is a lead sponsor of the conference. David Ross will be speaking on a panel discussion providing perspectives on the next decade for private debt.
Northleaf speaking at the Responsible Investment Forum: Europe
Jeff Pentland will be speaking on a panel discussion on ESG in infrastructure and how ESG can be used as part of a wider value creation strategy.
Northleaf speaking at ACG’s Capital Connection 2020
Northleaf is pleased to be a gold sponsor of the conference. Michael Bowman will be speaking on a panel discussion on structured equity solutions.
Northleaf speaking at the Marketplace Lending & Alternative Financing Summit 2020
Northleaf’s Michael Morris will be speaking on a panel discussion on how the private credit asset class has performed through COVID-19.